Newborn Screening for Lysosomal Storage Disorders: Quo Vadis?
Roy W A Peake(Boston Children's Hospital), Frits A. Wijburg(Emma Kinderziekenhuis), David S. Millington(Duke Medical Center), Michael H. Gelb(University of Washington), Olaf A. Bodamer(Broad Institute), Deborah Marsden(Boston Children's Hospital)
Cited by 26
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478